Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shree Ganesh Biotech (India) Ltd has informed BSE, CSE, and MSE that a Board meeting is scheduled for 14 May 2026. The primary agenda is to consider and approve the Audited Standalone Financial Results for the quarter and full year ended 31 March 2026, along with the Auditors' Reports. The meeting notice also includes a catch-all item for any other business the Board may deem fit. The notice is dated 04 May 2026, filed 10 days ahead of the meeting, complying with SEBI's Regulation 29 of the LODR Regulations, 2015. Scrip codes: BSE 539470, CSE 29221, MSE SHREEGAN.
This is a routine quarterly/annual results meeting notice. The meeting is being held 10 days in advance of the scheduled date, giving investors adequate notice. The approval of FY2026 audited results could trigger a positive or negative reaction depending on whether the numbers meet market expectations.